Decreasing Narcotics in Advanced Pelvic Surgery

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-operative recovery, and expedite return to baseline functional status. Pathways often are developed by a team of surgeons, nurses, pain specialists, anesthesiologists and other support staff. Postoperative components often involve multi-modal analgesia, early return to activity and early return to a regular diet. The goal of this study is to evaluate the efficacy of a multi-modal pain regimen in advanced pelvic surgery with a primary goal of decreasing narcotic usage.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hartford Hospital
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; BB 1101; Celecoxib; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Gabapentin; Hydromorphone; Ibuprofen; Narcotics; Ondansetron; Oxycodone

Criteria

Inclusion Criteria:

• women >/= 18 years old

• undergoing pelvic organ prolapse or incontinence surgery with the Urogynecology department

Exclusion Criteria:

• males

• <18 years old

• women unwilling or unable to consent

• same-day-discharge surgery

• history of chronic pain for which they use medications

• current or active history of narcotic abuse

• sleep apnea

• liver or kidney dysfunction

• sulfa allergy